NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
暂无分享,去创建一个
N. Reguart | B. Massuti | V. Calvo | M. Provencio | C. Camps | R. García-Campelo | A. Romero | E. Sánchez-Herrero | E. Jantus-Lewintre | S. Calabuig-Fariñas | M. Arnal | V. González-Rumayor | D. Fernández-Orth | R. Serna-Blasco | S. Sanz-Moreno | M. Dómine Gómez | V. Ivanchuk | José Miguel Sánchez | B. Massutí